Ipca Laboratories Reports Strong Q2 & H1 FY26 Financial Performance
Ipca Laboratories announced a robust financial performance for Q2 and H1 FY26. Standalone Net Total Income increased by 7% to ₹1952.24 crores.…
Granules India Reports Unaudited Standalone and Consolidated Financial Results for Q2 2026
Granules India Limited has announced its unaudited standalone and consolidated financial results for the second quarter and half-year ended…
Vishal Mega Mart Grants 40,25,000 Stock Options to Employees
Vishal Mega Mart has announced the grant of 40,25,000 stock options to its eligible employees and those of its subsidiary. The stock options…
Akzo Nobel India JSW Paints’ Acquisition to Trigger Debenture Trust Deed Obligations
Akzo Nobel India announced it has received notification from JSW Paints regarding the applicability of certain clauses of a debenture trust…
Niva Bupa Insurance Authority Approves Acquisition of 11.53 Crore Equity Shares
Niva Bupa Health Insurance has received approval from the Insurance Regulatory and Development Authority of India (IRDAI) for the proposed…
Bajaj Housing Finance Allotment of Secured NCDs on Private Placement Basis
Bajaj Housing Finance has allotted 50,000 secured redeemable non-convertible debentures (NCDs), with a face value of ₹1,00,000 each,…
Zydus Lifesciences ‘Andy’ Robotic Surgical System Receives CE Mark
Zydus Lifesciences’ subsidiary, Amplitude Surgical, has secured CE mark approval for its robotic surgical system, ‘Andy’.…
SBI Card Shamsher Singh Resigns as Non-Executive Nominee Director
Shamsher Singh has resigned from his position as Non-Executive Nominee Director at SBI Card, effective close of business hours on November 13,…
Amber Enterprises India Reports Q2 & H1 FY26 Results, Equity Funds Raised
Amber Enterprises India reported its Q2 & H1 FY26 results. The company delivered revenue of INR1,647 crores for the quarter. Despite a…
Lupin Achieves S&P Global ESG Score of 91, Sets New Sustainability Standard
Lupin has achieved an impressive S&P Global ESG Score of 91 for 2025, significantly exceeding the pharmaceutical industry average of 28.…